Stronger Sell Today VTGN ranks #2844 as SELL CANDIDATE. Weaker Sell
Today VTGN ranks #2844 as SELL CANDIDATE.

VTGN stock VistaGen Therapeutics Inc

VTGN stock
VistaGen Therapeutics Inc

Wed 12'th Dec 2018

PERIOD 2018-09-13 - 2018-12-12
CHANGE 0.00%




Request Prediction

VistaGen Therapeutics Inc Stock Analysis

Technical stock analysis for Wed 12'th Dec 2018

Sell candidate since 2018-12-11
Shorts n/a
Cash 13.0 mill
Loans 0.1 mill
Beta -1.29
ROA -347.91

No changes to the price of VistaGen Therapeutics Inc in the last trading day. The price has risen in 6 of the last 10 days and is up by 1.8% over the past 2 weeks.


VistaGen Therapeutics Inc lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $1.67 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 17.48% during the next 3 months and, with 90% probability hold a price between $1.96 and $2.90 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Tuesday December 11, 2018, which indicates further gains until a new top pivot has been found. Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". Some negative signals were issued as well, and these may have some influence on the near short-term development. VistaGen Therapeutics Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $1.75 and $1.89. A break-up above any of these levels will issue buy signals.

Access today's Top 5 Golden Star Companies

A buy signal from a double bottom formation was found on Tuesday December 11, 2018 and based on theory for this formation the price should go up by 0.14% to $1.84 within 3 trading days since signal was issued (Friday December 14, 2018).

Relative Strength Index (RSI)

RSI14 is 47 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $1.52 and $1.45.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, VistaGen Therapeutics Inc finds support just below today's level at $1.52. If this is broken, then the next support from accumulated volume will be at $1.45 and $1.39.

Support: $1.52 Price: $1.70 Resistance: $1.90


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.03 between high and low, or 1.78%. For the last week, the stock has had a daily average volatility of 3.72%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


The VistaGen Therapeutics Inc stock holds several negative signals and despite the positive trend we believe VistaGen Therapeutics Inc will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.

Stronger Sell Today VTGN ranks #2844 as SELL CANDIDATE. Weaker Sell
Today VTGN ranks #2844 as SELL CANDIDATE.